期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 84, 期 5, 页码 593-602出版社
WILEY
DOI: 10.1111/cbdd.12352
关键词
antidepressant activity; aroyl hydrazones; bromopyrrole alkaloids; MAOs inhibitors
资金
- College of Health Science, University of KwaZulu-Natal
- National Research Foundation South Africa (NRF)
Herein, we report synthesis and screening of a series of twenty derivatives of bromopyrrole alkaloids with aroyl hydrazone feature for antidepressant activity by forced swim test (FST), tail suspension test (TST), and actophotometer method. The molecules were further evaluated for in vitro human MAO's inhibitory activities. The tested compounds exhibited moderate to good antidepressant activity compared with standard fluoxetine. Among these, most promising antidepressant derivatives 5b (%DID=60.48), 5e (%DID=59), and 5j (%DID=74.86) reduced immobility duration of 50-70% at 30mg/kg dose levels in FST. Further, derivative 5b, 5e, and 5j displayed good antidepressant activity with %DID value of 47.50, 46.62, and 52.49, respectively, in TST compared with standard fluoxetine (66.56% DID). Compound 5b showed high in vitro MAO-A potency and selectivity (K-i MAO-A (m)=2.4 +/- 0.99, SI=0.06) with promising pharmacological activity recognizing its potential as antidepressant lead candidate for further drug development. Study revealed that the presence of halogen atoms such as chlorine and fluorine at ortho- and/or para-position of phenyl ring and N-alkylation of pyrrole core is favored features for antidepressant activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据